INTESTINAL DECARBOXYLATION OF L-DOPA IN RELATION TO DOSE REQUIREMENT IN PARKINSONS-DISEASE

被引：24

作者：

GRANERUS, AK

JAGENBURG, R

SVANBORG, A

机构：

[1] UNIV GOTHENBURG, VASA HOSP, DEPT GERIATRICS 2, GOTHENBURG, SWEDEN

[2] SAHLGRENS HOSP, DEPT CLIN CHEM, SF-41345 GOTHENBURG, SWEDEN

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1973年 / 280卷 / 04期

关键词：

D O I：

10.1007/BF00506633

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：429 / 439

页数：11

共 12 条

[1] DECARBOXYLATION OF ORALLY ADMINISTERED L-DOPA IN HUMAN DIGESTIVE TRACT [J].

BERGMARK, J ;

CARLSSON, A ;

SVANBORG, A ;

GRANERUS, AK ;

MAGNUSSON, T ;

JAGENBURG, R .

NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1972, 272 (04) :437-+

[2]

BERGMARK J, IN PRESS

[3] METABOLISM AND ABSORPTION OF L-3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSONS DISEASE [J].

BIANCHINE, JR ;

CALIMLIM, LR ;

MORGAN, JP ;

DUJUVNE, CA ;

LASAGNA, L .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :126-+

[4] DECREASE IN LIVER AROMATIC L-AMINO-ACID DECARBOXYLASE PRODUCED BY CHRONIC ADMINISTRATION OF L-DOPA [J].

DAIRMAN, W ;

CHRISTENSON, JG ;

UDENFRIEND, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (09) :2117-+

[5] METABOLISM OF 3,4-DIHYDROXYPHENYLALANINE (L-DOPA) IN HUMAN SUBJECTS [J].

GOODALL, MC ;

ALTON, H .

BIOCHEMICAL PHARMACOLOGY, 1972, 21 (17) :2401-+

[6] PHENYLALANINE ABSORPTION AND METABOLISM IN PARKINSONIAN PATIENTS [J].

GRANERUS, AK ;

JAGENBURG, R ;

RODJER, S ;

SVANBORG, A .

BMJ-BRITISH MEDICAL JOURNAL, 1971, 4 (5782) :262-+

[7]

GRANERUS AK, 1972, ACTA MED SCAND, V192, P1

[8]

PLETSCHER A, 1970, SCHWEIZ MED WSCHR, V100, P797

[9] L-3,4-DIHYDROXYPHENYLALANINE METABOLISM BY GUT IN-VITRO [J].

RIVERACALIMLIM, L ;

MORGAN, JP ;

DUJOVNE, CA ;

BIANCHINE, JR ;

LASAGNA, L .

BIOCHEMICAL PHARMACOLOGY, 1971, 20 (11) :3051-+

[10] ABSORPTION AND METABOLISM OF L-DOPA BY HUMAN STOMACH [J].

RIVERACALIMLIM, L ;

DUJOVNE, CA ;

MORGAN, JP ;

LASAGNA, L ;

BIANCHINE, JR .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1971, 1 (05) :313-+

← 1 2 →